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Abstract
Purpose The aim of this study was to evaluate the effect of
TheraBite exercises on mouth opening and to analyze factors
influencing this effect in a patient record evaluation.
Methods Effect of exercises with a TheraBite to treat trismus
was evaluated in 69 head and neck cancer patients of two
university medical centers. Mouth opening was measured as
interincisal distance in millimeters. Patient, tumor, and treat-
ment characteristics were analyzed for their relationship with
change in mouth opening. Variables univariately associated
(p≤0.05) with change in mouth opening were entered in a
logistic regression analysis as possible predictors for an in-
crease in mouth opening of the smallest detectable difference
of 5 mm or more.
Results Mean initial mouth opening was 22.0 mm (SD 6.4);
mean increase in mouth opening was 5.4 mm (SD 5.7).
“Chemotherapy”, “medical center”, and “time from onco-
logical treatment to start exercises” were significantly asso-
ciated with an increase in mouth opening. In the logistic
regression analysis, “medical center” (β01.97) and “time
from oncological treatment to start exercises” reduced the
odds of reaching an increase in mouth opening of 5 mm or
more, β0−0.11 per month.
Conclusions After TheraBite exercises, mouth opening in-
creased averagely with 5.4 mm. The odds of an increase in
mouth opening of 5 mm or more reduces if the time from
oncological treatment to start exercises lengthens, corrected
for the effect of medical center.
Keywords Head and neck neoplasms . Trismus . Exercise
therapy . Rehabilitation
Introduction
Trismus, a restricted mouth opening, is defined as a mouth
opening of 35 mm or less [1–3]. It is a well-known compli-
cation of cancer in the head and neck region and its treat-
ment. The prevalence of trismus ranges from 5 to 38 % [1].
The consequences of trismus can be serious; it can result in
problems with speech, oral hygiene, dental treatment, and
oncological follow-up [4–6]. Furthermore, trismus impacts
negatively on mandibular functioning and quality of life
[5, 7–9].
Trismus in head and neck cancer patients is difficult to
treat. Many (unusual) stretching techniques have been de-
scribed in case reports and case series. A sledgehammer, tied
to the mandible for 2 min twice a day, resulted in an increase
in mouth opening of 18 mm [10], An orthodontic “clothes
pin appliance” inserted between the molars and thereby
stretching mouth opening resulted in an increase of 6 mm
[11]. Further, application of a surgical mouthprop, a tapered
screw, a screw-type mouth gag, fingers, tongue depressors,
an intraoperatively fabricated self-curing bite block, and
interarch springs attached between maxillary and mandibu-
lar restorations have been described as methods to improve
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mouth opening but without providing information about the
actual increase in mouth opening [12–16]. Injection of
botulinum toxin in both masseter muscles did not show
improvement of mouth opening in head and neck cancer
patients [17]. Currently, no standard type of therapy to treat
trismus exits [18].
Historical cohort studies provided evidence that conven-
tional exercise therapy (using tongue depressors, fingers,
and rubber plugs) has some effect; mean increase in mouth
opening of 5.5 mm [19]. Jaw-stretching devices demon-
strated efficacy in improving trismus of head and neck
cancer patients in several studies with different designs
[18, 20–23].
Exercises with the Dynasplint® Trismus System (DTS)
increased mouth opening between the 6.2 and 13.6 mm, as
described in a case series, a preliminary report, and in a
retrospective study [18, 22, 23]. Exercises with the TheraBite®
Jaw Motion Rehabilitation System™ (TheraBite) increased
mouth opening with 13.6 and 10 mm, as described in a
randomized controlled trial with short follow-up (n021 with
10 weeks follow-up) and in a pilot study with small sample
size (n07 with 12–48 weeks follow-up), respectively [20, 21].
However, factors influencing the effect of TheraBite exercises
are unknown.
The aim of this study was to evaluate the clinical effect of
TheraBite exercise therapy to treat trismus secondary to
head and neck cancer and to analyze factors influencing this
effect in 69 head and neck cancer patients of two medical
centers. It was hypothesized that tumor and oncological
treatment characteristics, as well as time from oncological
treatment to start exercises influence the effect of TheraBite
exercises.
Methods
All head and neck cancer patients of two university med-
ical centers with trismus, treated with TheraBite exercise
therapy between April 2004 and July 2011 were included.
Characteristics regarding the cancer and its treatment were
obtained from medical records. Patients were referred from
the Department Head and Neck Oncology to the Depart-
ment of Physical Therapy for exercise therapy. Tumor
classification was based on the Union for International
Cancer Control recommendation (2009) TN classification
[24]. Trismus was defined as a mouth opening of 35 mm or
less [1].
The majority of the data were obtained retrospectively
from the medical/physical therapeutic records. However, 15
patients had not completed their exercise therapy at the start
of this study. Therefore, data of mouth opening of these
patients were collected prospectively at follow-up appoint-
ments. All of these patients gave written permission for the
use of these data for scientific purposes. The institutional
review board approved this study.
TheraBite exercises
Exercises with the TheraBite are patient-controlled. The
mouthpieces are placed between the maxilla and mandible.
The stretching effects occur when the handle of the
TheraBite is squeezed. During their first visit to the Depart-
ment of Physical Therapy, patients were familiarized with
the use of the TheraBite and received exercise instructions.
Follow-up appointments were routinely planned every
2 weeks to evaluate possible difficulties encountered during
the exercise therapy. Generally, about three instruction ses-
sions were held to inform and motivate the patient. When
the patient was comfortable with the exercises, follow-up
was planned individually. Patients were instructed that pain
during the stretch was normal, but excessive pain should be
avoided. Additionally, patients were informed that their
teeth or alveolar ridges could become painful because of
the pressure. During the TheraBite exercise therapy, patients
did not receive concomitant treatments to improve mouth
opening.
Exercises were performed according to instructions
given by the physical therapist. Patients in the first
medical center (Radboud University Nijmegen Medical
Center; RUNMC) received the instruction to exercise
four sessions each day, with 6–8 repetitions within each
session, and hold the stretch for 10–15 s. In the second
medical center (University Medical Center Groningen;
UMCG), the instructions were to perform the exercises
five sessions each day, with 6 repetitions within each
session, and hold the stretch for 6 s. Patients were
encouraged to continue exercising following this schedule
until no further improvement in mouth opening could be
achieved.
Measurement of mouth opening
Mouth opening was measured prior to TheraBite exercises
and at regular follow-up appointments by using a slide
caliper. In patients with complete frontal dentition, mouth
opening was measured as the maximal interincisal distance.
In edentulous patients wearing dentures, distance between
the incisors of the upper and lower dentures was measured.
In edentulous patients not wearing dentures, maximal dis-
tance between the two alveolar ridges was measured. In
patients with one edentulous and one jaw with frontal den-
tition wearing dentures, distance between the incisor of
denture and the incisor was measured. In patients with one
edentulous en one jaw with frontal dentition not wearing
dentures, distance between the alveolar ridge and the incisor
was measured.
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Statistical analyses
Statistical analyses were performed using SPSS 18.0 for
Windows software (SPPS Inc., Chicago, IL, USA). In the
univariate analyses, associations between patient, tumor,
and treatment characteristics (predictor variables) and the
increase in mouth opening of 5 mm or more (outcome
variable) were analyzed by means of Mann–Whitney U
(MWU), Kruskal–Wallis, and Spearman’s rho (ρ). Variables
univariately associated (p≤0.05) with the outcome variable
“increase in mouth opening of 5 mm or more” (yes, no)
were entered in the multivariate logistic regression analysis
(stepwise backward). This increase of 5 mm or more corre-
sponds with the smallest detectable difference of single
measurement of mouth opening in patients with head and
neck cancer [25].
The following predictor variables were analyzed regarding
their relationship with increase in mouth opening: gender
(female, male), squamous cell carcinoma (yes, no), radiother-
apy (yes, no), surgery (yes, no), chemotherapy (yes, no),
chemoradiation (yes, no), medical center (RUNMC, UMCG),
T classification (T1–T3, T4), tumor site (oral cavity; oro-,
naso-, hypopharynx; temporomandibular joint region), age
(years), initial mouth opening (millimeters), duration of exer-
cise therapy (months), and time from oncological treatment
(counted from last date of the surgery, chemotherapy, radio-
therapy, or chemoradiation) to start (TheraBite) exercises
(months).
Results
Between April 2004 and July 2011, 72 patients were pro-
vided with a TheraBite. Measurements of mouth opening
pre and post exercises were available of 69 patients. Of three
patients, no measurement of final mouth opening was avail-
able because they deceased due to their cancer during the
exercise therapy. They were excluded. Dental status of none
of the patients changed between initial measurement and last
measurement of mouth opening. Patient and tumor charac-
teristics are presented in Table 1. Mean initial mouth open-
ing was 22.0 mm (SD 6.4). Mean increase in mouth opening
after TheraBite exercises was 5.4 mm (SD 5.7). In 37
patients (54 %), mouth opening increased with 5 mm or
more. Of 49 patients (71 %), the tumor was staged as T4. Of
nine patients, TN classification was missing: five of these
patients had a recurrence, two patients an osteosarcoma, one
patient an adenoid cystic carcinoma, and one patient had a
rhabdomyosarcoma 18 years ago (Table 2).
In one patient, the reconstruction plates fractured during
TheraBite exercises therapy; this was diagnosed during
oncological follow-up by means of an orthopantomogram.
The patient was treated with surgery and postoperative
radiotherapy for a pT4N0 squamous cell carcinoma in the
lower jaw. The mandibular reconstruction had been per-
formed with a free vascularized fibula transplant, fixated
with titanium plates. During exercises, the patient com-
plained of grating sounds that were initially interpreted as
crepitation arising from the temporomandibular joint.
Table 1 Patient characteristics (n069) and tumor characteristics









Age in years 53.9 (14.9)
Initial mouth opening in mm 22.0 (6.4)
Increase in mouth opening in mm 5.4 (5.7)
Increase of 5 mm or more 37 (53.6)
Duration of exercise therapy in months 6.3 (5.6)
Time from oncological treatment to
start exercises in monthsa
15.1 (38.7)
Type of tumor
Squamous cell carcinoma 49 (71.0)
Salivary gland carcinoma 6 (8.7)
Rhabdomyosarcoma 4 (5.8)
Osteosarcoma 3 (4.3)
Merkel cell carcinoma 2 (2.9)
Meningioma 1 (1.4)
Chondrosarcoma 1 (1.4)
Epidermoid cyst 1 (1.4)
Adenoid cystic carcinoma 1 (1.4)
Unknownb 1 (1.4)
Site of tumor
Oral cavity 33 (47.8)
Oro-, naso-, hypopharynx 28 (40.6)
Temporomandibular joint region 18 (11.6)
a Some patients started TheraBite exercise therapy before ending
radiotherapy
b One patient with a large cell carcinoma was treated with chemother-
apy and radiation, no final pathology rapport was present
Table 2 TN
classification N0 N1 N2 N3
T1 4 0 2 0
T2 4 4 5 0
T3 1 0 1 0
T4 6 4 28 1
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Approximately 6 weeks after the plate fracture was diag-
nosed, it became clear she was suffering from a large
inoperable recurrence. If this patient was excluded from
the statistical analysis, mean increase in mouth opening
changed to 5.5 mm (SD 5.7). For further data analyses, her
data were excluded.
Results of statistical analyses
Variables significantly associated with increase in mouth
opening were: “chemotherapy” (MWU, p00.04), “medical
center” (MWU, p00.01), and “time from oncological treat-
ment to start exercises” (ρ0−0.516, p<0.01) (Table 3).
These variables were entered in the logistic regression anal-
ysis. If the time between oncological treatment and start
exercises lengthens, the odds of obtaining a mouth opening
5 mm or more reduced, while being treated in the RUNMC
increased the odds (Table 4, Fig. 1).
Discussion
On average, mouth opening improved 5.4 mm (SD 5.7) after
TheraBite exercises. The factors influencing the efficacy of
TheraBite exercises were chemotherapy, medical center, and
time from oncological treatment and start exercises in the
univariate analysis. The influence of medical center on the
effect of exercises may be caused by differences in patient
population, exercise protocol, or by compliance to the exercise
therapy. Also unknown center effects may be responsible for
differences between centers. Effects of radiotherapy on in-
crease in mouth opening were not found in this study,
probably because that the majority of the patients (78 %)
received radiotherapy.
The results of the logistic regression analysis showed that
the odds of reaching an increase in mouth opening of 5 mm
or more reduced if the time from oncological treatment to
start exercises lengthened and if patients were treated in the
UMCG. Chemotherapy did not significantly influence the
odds of reaching an increase in mouth opening of 5 mm or
more in the logistic regression analysis, maybe due to lack
of adequate sample size. Thus, our initial hypothesis was
only partially confirmed. Clinically, our results indicate
that if patients start with the exercises after 1 year after
the oncological treatment in the UMCG, the odds ratio of
improving mouth opening with 5 mm of more is 0.27,
e(12*−0.108), compared to a person who starts immediately
after the oncological treatment (Fig. 1).
If trismus, caused by surgery or radiotherapy and the
related fibrosis (scar tissue), exists for a certain period, the
restriction may become more resistant to exercise therapy
due to maturation of scar tissue [26]. This maturation can
explain the reduced of the effect of exercise therapy when
the time from oncological treatment to start exercises length-
ens. Results of previous studies suggest that TheraBite ex-
ercise therapy is superior in increasing mouth opening
compared to conventional exercise therapy [20, 21]. Based
on those results, head and neck cancer trismus patients were
Table 3 Univariate analyses of
independent variables related to





Variables Increase in mouth opening Median (IQR) Test, significance
Gender Male Female
3.0 (1.5;7.5) 5.5 (1.3;9.8) MWU, p00.29
Yes No
Squamous cell carcinoma 4.0 (2.0;8.0) 5.0 (0.0;9.8) MWU, p00.74
Radiotherapy 5.0 (1.0;8.0) 5.0 (2.0;7.0) MWU, p00.75
Surgery 6.0 (1.0;9.0) 3.0 (1.5;5.5) MWU, p00.10
Chemotherapy 2.0 (0.0;4.3) 6.0 (2.0;9.0) MWU, p00.04
Chemoradiation 4.5 (2.3;6.8) 5.0 (1.0;8.5) MWU, p00.81
Medical center RUNMC UMCG
7.0 (3.0;8.5) 2.0 (0.0;6.0) MWU, p00.01
T classification T1-T3 T4
6.0 (2.0;8.0) 4.0 (0.0;8.0) MWU, p00.38
Tumor site Oral cavity 6.0 (1.0;8.5) KW, p00.32
Oro-, naso-, hypopharynx 2.5 (1.3;7.0)
Temporomandibular joint region 8.0 (1.5;10.5)
Age ρ00.166, p00.17
Initial mouth opening ρ00.014, p00.91
Duration of exercise therapy ρ0-0.100, p00.42
Time from oncological treatment to
start exercises
ρ0-0.516, p<0.01
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provided with a TheraBite routinely in our centers. However,
the results of those studies could not be confirmed in our
study. The superior effects of exercises with a TheraBite in
those studies might also be related to the sample size, popu-
lation characteristics, or time from oncological treatment to
start exercise.
It is possible that the effect of TheraBite exercises in this
study is smaller than those found in 1993 by Buchbinder et
al. due to confounding by indication. This type of confound-
ing indicates that patients were referred only if they had a
severely restricted mouth opening. When comparing the
mean initial mouth opening and standard deviations of our
patients (21.8 mm, SD 6.6) and those of Buchbinder et al.
(21.3 mm, SD 1.7), it can be seen that only standard devia-
tions differ between the groups. In our group, a larger
variation in initial mouth opening was present [20].
In a pilot study of Cohen et al. in 2005, the mean increase
in mouth opening after TheraBite exercises was 10 mm
(SD 8.1) [21]. The difference in gain in mouth opening
between that and our study might be explained by differ-
ences in population. Additionally, patients in the study of
Cohen et al. began their exercises within 6 weeks after
surgery and had a less severely restricted mouth opening
prior to the exercises (initial mouth opening of 40 mm
versus 22.0 mm in our population). Moreover, only two of
the seven patients (29 versus 78 % in our population) were
treated with radiotherapy before the exercise therapy started
[21].
Mouth opening increased with a comparable amount of
millimeters (6.2 mm, SD 3.4) when trismus was treated with
another type of mechanical stretching device, the DTS. In
that study, the interval between oncological treatment and
initiation of exercise therapy was approximately 4 years
[23]. In a preliminary report and in a case series, mouth
opening increased on average with 11.0 and 13.6 mm, re-
spectively, after exercises with the DTS [18, 22].
Regression to the mean might explain the increase in
mouth opening in the current study, indicating that a patient
seeks help at the peak of the burden of symptoms (a max-
imally restricted mouth opening). Restricted mouth opening
shows a random variation over time. Due to this variation, it
can be expected that mouth opening increase after some
time independent of any intervention. However, in head
and neck cancer patients, who have been treated with radio-
therapy, mouth opening decreases over time [27]. Thus, we
assume that regression to the mean is not a likely explana-
tion for the increase in mouth opening and that the increase
can be attributed to the exercises.
The fracture of a titanium reconstruction plates during
TheraBite exercises is an adverse effect that can be
explained by non-union of the fibula to the mandible, by
the recurrence of carcinoma, or by excessive stretching
forces. When prescribing exercises with a TheraBite in cases
of bony reconstructions of the mandible, exercise forces
should be limited until consolidation of the reconstruction
is completed.
Since it is difficult to treat a head and neck oncology-
related trismus, more attention should be paid to prevent
trismus by applying intensity modulated radiotherapy when
possible or by starting (TheraBite) exercises during or
Table 4 Multivariate logistic regression analysis (stepwise backward) with an increase in mouth opening of 5 mm or more as outcome variable
β Standard error β P value Odds ratio 95 % confidence interval
Lower Upper
Medical centera 1.967 0.70 0.005 7.094 1.83 27.51
Time from oncological treatment to start exercises −0.108 0.04 0.003 0.897 0.84 0.96
Constant 0.197 0.42 0.638 1.218 0.53 2.77
a Reference center is UMCG
























Fig. 1 Increase in mouth opening plotted against time from oncological
treatment to start exercises
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immediately after oncological treatment [28]. However,
exercises may not be effective in preventing a decrease in
mouth opening [29]. In our study, patients were encouraged
to continue exercise therapy until no further improvement in
mouth opening was achievable. Compliance to exercise
therapy is dependent on internal motivation and the per-
ceived effect of exercises. Perceiving no treatment effect,
reaching the exercise goal, and an insufficient opening range
of the TheraBite have a negative effect on adherence [4].
None of the patients, who started with the exercises after
3 years, reached more gain in mouth opening than 3 mm.
Therefore, the value of this type of exercises after an interval
of 3 years is limited (Fig. 1).
In this study, no patients were excluded from a TheraBite
for financial reasons. However, based on the outcome of this
study, not every patient should straightforwardly be treated
with exercise therapy with a TheraBite because of the high
costs of the apparatus and the comparable effects of the
much cheaper conventional exercise therapy. To the best of
our knowledge this study included the largest sample of
patients treated for a head and neck oncology-related tris-
mus using a TheraBite. The overall absolute increase in
mouth opening using a TheraBite found in this study was
comparable to conventional exercise therapy [19].Patients
should be informed about the results they can expect of
TheraBite exercise therapy.
Study limitations
Limitations of the current study are lack of a control group,
its primarily retrospective design, lack of the assessment of
compliance, and a non-blinded assessment of mouth open-
ing that may have led to an over- or underestimation of the
effect of TheraBite exercises. Because most data were gath-
ered before the intention of the study was clear, we assume a
random error in measuring mouth opening. Different per-
sons in two medical centers measured mouth opening, but
mouth opening can be measured reliably; therefore, we
assume that this had no systematic effect on the outcome
of this study [25]. Another limitation is that all patients who
were referred for TheraBite exercises were included in the
study, resulting in considerable heterogeneity in patient pop-
ulation and oncological treatment characteristics. However,
this heterogeneity reflects clinical practice and therefore
enhances external validity. Finally, a limitation of the study
is that the effect TheraBite exercise therapy only was mea-
sured as mouth opening in millimeters. Mandibular function-
ing or quality of life was not assessed; however, the TheraBite
is primarily developed for increasing mouth opening.
Further research is needed to compare the TheraBite with
the DTS in a randomized controlled trial. The costs of a
DTS are about five times higher than those of a TheraBite.
Cost effectiveness of both jaw-stretching devices should be
analyzed. Effects of the exercises should ideally be mea-
sured in millimeters, in mandibular functioning, and in
quality of life.
Conclusions
Mouth opening increased averagely with 5.4 mm after exer-
cises with the TheraBite. The results indicate that the odds of
an increase in mouth opening of 5 mm or more reduces if the
time from oncological treatment to start exercises lengthens,
corrected for the effect of medical center.
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